Market cap
$95 Mln
Revenue (TTM)
$10 Mln
P/E Ratio
--
P/B Ratio
7.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 96.53 | 104.16 | 39.05 | 24.48 | -12.10 |
| EBIT | 1.72 | 9.16 | 9.04 | -8.19 | 1.06 |
| Net Profit | -14.46 | -24.62 | -3.84 | -17.41 | -4.57 |
| EPS | -13.19 | -9.96 | 4.87 | 10.48 | 13.98 |
| Book Value | -- | -- | -68.34 | -46.38 | -58.25 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-23 | Dec-22 |
| EBIT-Margin
| -914.49 | -1,268.23 | -721.18 | -910.92 | -1,051.46 |
| Net Margin
| -760.58 | -1,224.68 | -850.75 | -- | -952.49 |
| Return on equity
| -76.07 | -93.43 | -- | -117.89 | -56.20 |
| Return on Capital
| -71.62 | -86.85 | -- | -108.72 | -53.95 |
| Return on Assets
| -61.99 | -72.34 | -100.09 | -88.83 | -49.95 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.17 | 0.06 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
-108.72
|
-53.95
|
-52.20
|
-98.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
-117.89
|
-56.20
|
-54.12
|
-101.30
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-100.09
Lower than Peers by 102.55
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-100.09
|
-88.83
|
-49.95
|
-47.19
|
-77.51
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-721.18
Lower than Peers by 729.65
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-721.18
|
-910.92
|
-1,051.46
|
-781.07
|
-1,785.76
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-850.75
Lower than Peers by 855.43
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-850.75
|
-914.46
|
-952.49
|
-568.66
|
-2,152.89
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
39.05
Higher than Peers by 30.56
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
39.05
|
0.21
|
-0.14
|
1.59
|
-0.63
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
9.04
Lower than Peers by 1.61
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
9.04
|
-4.85
|
-15.89
|
-13.40
|
63.32
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
-3.84
Lower than Peers by 17.39
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-3.84
|
-3.80
|
-20.97
|
-5.31
|
61.54
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
4.87
Lower than Peers by 15.64
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
4.87
|
0.02
|
-0.16
|
0.67
|
0.90
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
-116.25
Lower than Peers by 123.26
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-116.25
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
0.17
|
0.06
|
0.03
|
0.05
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.45
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-1.45
|
0.03
|
0.01
|
0.00
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.49
Lower than Peers by 2.34
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
0.49
|
2.88
|
8.34
|
11.50
|
3.31
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
0.31
Lower than Peers by 1.74
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
0.31
|
2.31
|
7.55
|
10.63
|
2.33
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-122.25
Lower than Peers by 127.21
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-122.25
|
-2,604.33
|
-181.75
|
-173.78
|
-2,984.11
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
4.12
Lower than Peers by 12.33
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
4.12
|
40.90
|
39.65
|
25.02
|
35.12
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.12
Lower than Peers by 0.38
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
0.12
|
0.10
|
0.05
|
0.06
|
0.04
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
134.53
|
125.50
|
70.44
|
99.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
207.43
|
284.18
|
307.25
|
731.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
100.56
|
114.16
|
89.09
|
195.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
241.39
|
295.52
|
288.60
|
635.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
-1.02
|
-1.09
|
-4.03
|
-0.75
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
7.09
Higher than Peers by 3.26
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
7.09
|
2.39
|
0.83
|
1.49
|
0.72
|
|
Peer Median
|
3.84
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.78
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
-0.78
|
-0.87
|
-0.28
|
-3.17
|
-0.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
95
Lower than Peers by 447
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
95
|
--
|
--
|
--
|
--
|
|
Peer Median
|
542
|
--
|
--
|
--
|
--
|